Beijing Beilu Pharmaceutical Asset Resilience Ratio

Latest as of September 2025: 10.67%

Beijing Beilu Pharmaceutical asset resilience ratio. Beijing Beilu Pharmaceutical (300016) has an Asset Resilience Ratio of 10.67% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Beilu Pharmaceutical (300016) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥343.64 Million

≈ $50.28 Million USD Cash + Short-term Investments

Total Assets

CN¥3.22 Billion

≈ $471.45 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of Beijing Beilu Pharmaceutical (2005–2024)

Asset resilience ratio of Beijing Beilu Pharmaceutical from 2005 to 2024. This chart shows how Beijing Beilu Pharmaceutical's Asset Resilience Ratio has changed over time. Read 300016 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Beijing Beilu Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Beijing Beilu Pharmaceutical.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥343.64 Million	10.67%
Total Liquid Assets	CN¥343.64 Million	10.67%

Asset Resilience Insights

Moderate Liquidity: Beijing Beilu Pharmaceutical has 10.67% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Beijing Beilu Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Beijing Beilu Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Beijing Beilu Pharmaceutical Asset Resilience Ratio by Year (2005–2024)

Beijing Beilu Pharmaceutical asset resilience ratio by year from 2005 to 2024. The table below shows the annual Asset Resilience Ratio data for Beijing Beilu Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.78%	CN¥350.77 Million ≈ $51.33 Million	CN¥2.98 Billion ≈ $435.71 Million	+12.39pp
2023-12-31	-0.61%	CN¥-17.20 Million ≈ $-2.52 Million	CN¥2.82 Billion ≈ $412.57 Million	-0.08pp
2022-12-31	-0.53%	CN¥-14.79 Million ≈ $-2.16 Million	CN¥2.82 Billion ≈ $412.00 Million	-0.15pp
2021-12-31	-0.38%	CN¥-11.00 Million ≈ $-1.61 Million	CN¥2.90 Billion ≈ $424.78 Million	-0.13pp
2020-12-31	-0.25%	CN¥-7.14 Million ≈ $-1.04 Million	CN¥2.85 Billion ≈ $416.69 Million	+0.21pp
2019-12-31	-0.46%	CN¥-7.47 Million ≈ $-1.09 Million	CN¥1.62 Billion ≈ $237.62 Million	-0.41pp
2018-12-31	-0.05%	CN¥-666.64K ≈ $-97.55K	CN¥1.29 Billion ≈ $188.58 Million	-5.80pp
2016-12-31	5.75%	CN¥55.00 Million ≈ $8.05 Million	CN¥956.09 Million ≈ $139.91 Million	+4.63pp
2005-12-31	1.13%	CN¥1.21 Million ≈ $177.06K	CN¥107.46 Million ≈ $15.72 Million	--

pp = percentage points

About Beijing Beilu Pharmaceutical

SHE:300016 China Drug Manufacturers - Specialty & Generic

Market Cap

$658.93 Million

CN¥4.50 Billion CNY

Market Cap Rank

#10580 Global

#2819 in China

Share Price

CN¥8.00

Change (1 day)

+1.91%

52-Week Range

CN¥7.23 - CN¥11.19

All Time High

CN¥27.25